Dhruv Shah

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Despite considerable progress in recent years, the overall prognosis of metastatic malignant melanoma remains poor, and curative therapeutic options are lacking. Therefore, better understanding of molecular mechanisms underlying melanoma progression and metastasis, as well as identification of novel therapeutic targets that allow inhibition of metastatic(More)
  • 1